BARCELONA, Spain, September 9, 2010 /PRNewswire/ -- Elekta will demonstrate its continued leadership role in the technological advancement of radiation oncology at the 2010 meeting of the European Society for Therapeutic Radiology and Oncology (ESTRO) 12-16 September in Barcelona, Spain. Elekta's theme is Experience the Elekta Difference, which acknowledges the importance of listening to customers and delivering what they need-in image guidance, digital control, field shaping, respiratory motion management, treatment speed and accuracy.
Our Experience the Elekta Difference theme distinguishes Elekta from other providers, says Olof Sanden, Executive Vice President, Europe and AFLAME. We believe our customers should be the principle drivers of innovation based on their clinical needs. The difference is how Elekta translates listening and collaboration with customers into practical solutions that our customers can employ in the clinic.
To bring its ESTRO 29 theme to life, Elekta booth #040 will feature a 3D hologram theatre designed to show visitors how the company's tradition of listening has equipped clinicians with the tools they need to optimize patient care. Elekta also will exhibit several new, developing and field-proven solutions, including:
- Agility* multileaf collimator (MLC) prototype. Featuring a leaf positioning system that utilizes optical technology to verify and ensure accuracy, Agility will provide low transmission with unparalleled leaf speed. In addition, Agility will offer 160, 5mm leaves across the full 40 x 40cm field to provide a single, versatile MLC for a spectrum of applications. To download a white paper highlighting the scientific principles used to design Agility, visit http://www.elekta.com/agility. - Integrity(TM)* digital linear accelerator control. Now in its sixth generation, Elekta's digital linac control synchronizes multiple linac operations through a single centralized control system to increase performance and reduce the risk of errors. To download a white paper detailing three clinical sites' experience with Integrity, visit http://www.elekta.com/integrity. - Intuity(TM) image guidance for tumors and critical structures. Building upon Elekta's XVI imaging technology, Intuity offers superior image quality combined with the largest available image size. - Symmetry(TM) respiratory motion management for lung tumor treatment. Revolutionizing the process of visualizing moving tumors during treatment, Symmetry enables clinicians to reduce margins, account for baseline shifts and employ uninterrupted treatment delivery while the patient breathes freely. - Monaco(R) treatment planning with VMAT. With reduced planning time and increased clinical throughput, Monaco with VMAT optimizes single or multiple non-coplanar arcs simultaneously, providing the flexibility and control needed for complex treatment plans. - Clarity(TM)** soft tissue visualization. Capable of integrating with any linac platform, Clarity takes breast and prostate soft tissue visualization for planning and patient set-up to new levels. Easy to learn and use, Clarity seamlessly integrates within existing clinical workflows. - Leksell Gamma Knife(R) Perfexion(TM) stereotactic radiosurgery system for treatment of multiple metastases with speed and precision.
Events held in conjunction with ESTRO
Prior to ESTRO, Elekta will host its 2010 European Users Meeting Saturday, 11 September at the Pullman Skipper Hotel. An interactive forum, attendees will have the opportunity to hear customers share their clinical experience utilizing Elekta's advanced treatment methodologies, adaptive and enhanced planning tools and oncology information systems. In addition, Elekta will host two lunch symposia:
- Elekta Oncology: Innovations in Image Guidance and VMAT, Tuesday, 14 September from 12:45 - 14:30 in Room 113, Level 1. - Elekta Neuroscience: Solutions for Stereotactic Radiotherapy, Wednesday, 15 September from 12:45 - 14:30 in Room 115, Level 1.
To learn more about Elekta's innovations at ESTRO, visit http://www.elekta.com/experience.
*Works in progress and not available for sale or distribution.
**Clarity is not for sale or distribution in all regions. Please contact your local Elekta representative or authorized distributor for further details.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit http://www.elekta.com.
CONTACT: Stina Thorman, Vice President Corporate Communications, ElektaAB, +46-8-587-254-37, email: firstname.lastname@example.org, Time zone: CET:Central European; Michelle Lee, Director, Global Public Relations and BrandManagement, Elekta, +1-770-670-2447, email@example.com, Time zone:EDT: Eastern Daylight